In addition, studies with larger sample sizes and in-depth mechanism analysis are also warranted to systematically elaborate the relationship between breast tissue microbiomes and other indicators strongly associated with breast cancer, such as epidermal growth factor receptor 2 (HER2), and their impact on breast cancer. Here, ERBB2 is linked to breast carcinoma.